During the past decade, Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 9 clinical trials were completed, i.e. on average, 28.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 7 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Baskent University" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Jiangsu HengRui Medicine Co., Ltd." with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Breast Neoplasms" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Breast Cancer" (2 trials) and "Neoplasm Metastasis" (2 trials). Many other conditions were trialed in "Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology" in a lesser frequency.

Most popular intervention types in "Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology" are "Drug" (41 trials), "Other" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (10 trials), "Placebo" (9 trials), "Atezolizumab" (8 trials), "Cisplatin" (7 trials) and "Gemcitabine" (6 trials). Other intervention names were less common.

The vast majority of trials in "Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology" are 35 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology". undefined are not yet recruiting, 11 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".